The Board of Cell Therapies Pty Ltd (CTPL) has announced that Dr Dawn Driscoll will be stepping down from her post as CEO, effective 31 Dec 2020.
A. Prof. Leslie Reti AM, Chairman, said “The Board, Management and Staff of CTPL would like to thank Dawn for her commitment and stewardship of the company over her past 3 years as CEO”.
In this time CTPL has grown from a small but highly specialised manufacturer and distributor of cell-based therapies into a significantly larger and more robust globally-active commercial contract development and manufacturing company.
The recruitment search for a new CEO, resident in Melbourne, will now commence. A. Prof. Dominic Wall will be acting CEO from 1st of January 2021 until the new CEO commences.
